Vuong Trieu's Net Worth
$4.5 Million
Who is Vuong Trieu?
Vuong Trieu has an estimated net worth of $4.5 Million. This is based on reported shares across multiple companies, which include Marina Biotech, Inc., Sorrento Therapeutics, Inc., and Oncotelic Therapeutics, Inc..
SEC CIK
Vuong Trieu's CIK is 0001587074
Past Insider Trading and Trends
2018 was Vuong Trieu's most active year for acquiring shares with 11 total transactions. Vuong Trieu's most active month to acquire stocks was the month of March. 2018 was Vuong Trieu's most active year for disposing of shares, totalling 4 transactions. Vuong Trieu's most active month to dispose stocks was the month of February. 2018 saw Vuong Trieu paying a total of $1,664,900.00 for 3,846,522.98 shares, this is the most they've acquired in one year. In 2018 Vuong Trieu cashed out on 500,000 shares for a total of $250,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Marina Biotech, Inc. (ATRX) No price found
Executive ChairmanVuong Trieu owns 1,474,784 units of Common Stock. From 2016 to 2018 Vuong Trieu acquired a total of 40,368,121 shares in Marina Biotech, Inc. at a cost of $262,649.72, Vuong also disposed a total of 500,000 shares of Marina Biotech, Inc. equalling to $250,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -44.94% | -500.00K |
$0.50 | -$250,000.00 | 612.72K |
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +0.09% | 10K |
$0.39 | $3,900.00 | 11.13M |
Jun 9
| |||
Form 4
| +0.10% | 22.5K |
$0.39 | $8,750.00 | 22.21M |
Jun 7 - Jun 8
| |||
Form 4
|
∞
| 862.07K |
$0.29 | $249,999.72 | 862.07K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 39.47M |
—
|
—
| 39.47M |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sorrento Therapeutics, Inc. (SRNEQ) Snapshot price: $0.058
CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncotelic Therapeutics, Inc. (OTLC) Snapshot price: $0.03975
CHAIRMAN AND CEOVuong Trieu owns 115,272,130 units of Common Stock which is worth $4,582,067.17. From 2019 to 2023 Vuong Trieu acquired a total of 95,806,595 shares in Oncotelic Therapeutics, Inc. at a cost of $64,816.88.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.27% | 500K |
$0.03 | $10,875.00 | 183.66M |
Jun 28 - Jun 29
| |||
Form 4
| +0.11% | 100K |
$0.03 | $2,600.00 | 91.54M |
Jun 16
| |||
Form 4
| +0.44% | 400K |
$0.03 | $13,040.00 | 91.44M |
Jun 14
| |||
Form 4
| +0.14% | 126.89K |
$0.03 | $4,326.88 | 91.04M |
May 26
| |||
Form 4
| +0.11% | 100K |
$0.05 | $4,500.00 | 90.92M |
May 2
| |||
Form 4
| +0.13% | 120K |
$0.05 | $6,000.00 | 90.56M |
Dec 6
| |||
Form 4
| +0.08% | 70K |
$0.08 | $5,600.00 | 90.44M |
Nov 22
| |||
Form 4
| +0.02% | 20K |
$0.07 | $1,360.00 | 90.37M |
Sep 26
| |||
Form 4
| +0.09% | 80K |
$0.08 | $6,560.00 | 90.35M |
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 4
| +472.50% | 94.24M |
—
|
—
| 114.18M |
Mar 31 - Jul 8
| |||
Form 4
| +0.32% | 50.5K |
$0.19 | $9,595.00 | 15.81M |
Nov 19
| |||
Form 4
| +0.02% | 3K |
$0.12 | $360.00 | 15.76M |
Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||